T h e use of antibiotics in the treatment of Actute Otitis Media (AOM) remains controversial, as reflected by the spate of reccent papers 12,3,4 on the management of this very common condition. The benefits of antibiotic treatment on short term and long term outcomes remain unproved ; uncertainity exists over whether antibiotics prevent rare complications and studies on prevention of poor outcome in high-risk groups follwing antibiotic treatment are lacking.
It is broadly believed that community-based services would usually favour the use of antibiotics, especially in the U.K. and U.S. A s. 6,z, though not in the Netherlands 8. The hospital departments w o u l d be advocating its use whilst dealing with treatment failures, high-risk groups and the treatment of the complications of actute otitis media.
Conservative therapy
The mainstay of conservative therapy has been analgesicsNon-steroidal anti-inflammatory. To prevent one child from experiencing pain by 2-7 days of presentation, 17 children must be treated early with antibiotics. They suggested a selective and more restricted use of antibiotics, and that looking for subgroups of children with otitis media who are going to suffer beyond one day and thus benefit most from antibiotics might be an useful of research in future.
A b s t r a c t

The role of Tympanocentesis
More recently, measuring antibiotic concentrations in middle-ear fluid (MEF) has been used to assess the efficacy of antibiotic regime, especially in children who have had treatment failure in the presence of betalactamase. 32 Several beta-lactamase stable drugs e.g. cefixime and amoxycillinclavulanate achieve MEF concentrations well above the Minimum Inhibitory Concentration (MIC) 90-s for both beta-lactamase producing and non-producing Haemophilus influenzae, which was a distinct advantage over amoxycillin, as the latter failed to achieve the MIC 90 for most strains of beta-lactamase producing H. influenzae. But amoxycilin remains the first-line agent of choice by virtue of its superiority over amoxycilin-clavulanate or cefixime in reaching MEF levels that exceed the MIC 90 for penicillin-resistant Streptococcus pneumoniae at normal doses. Thus tympanocentesis with culture is the ideal method of antibiotic choice, atleast in children with multiple antibiotic-regime failures 33 to decide between first and second-line agents. Clarithromycin 34 has been reported to produce sustained MEF concetrations well above the MIC 90-s for most otitic pathogens with multiple oral doses.
It is possible that while empiric therapy could be restricted to first-line agents like amoxycillin, treatment of therapeutic failures with the former might be an indication to choose second-line agents based on tympanocentesis and culture in the near future. Moreover in the areas of high prevalence of beta-lactamase producing organisms, the appropriate first-line agent for empiric therapy could be chosen on the basis of clinical efficacy as predicted by MF levels. 35 More prospective studies are required to establish a protocol for choosing second-line antibiotics.
Prophylactic therapy for recurrent A OM
At present the sub-population of children having recurrent episodes of acute otitis media can be best managed by a number of approaches. Long-term low-does antibiotics have proved adequate with few side-effects 36,37, and overgrowth of Clostridium difficile has never been reported2 8 A recent American study 39 however found no benefit of continuous twice-daily or once-daily amoxycillin prophylaxis over placebo in preventing new AOM episodes. The use of routine antibiotic prophylaxis over placebo in preventng new AOM episodes. The use of routine antibiotic prophylaxis was therefore discouraged in this study, keeping in view the risk of acquisition of resistant pneumococck Surgical interventions like adenoidectomy 4~ and insertion of ventilating tubes 42 have also been effectively used, although long-term sequelae of the later intervention might make it seem less than ideal. More recently, Uhari et a143 have reported from Finland the effectiveness of xylitol administered through chewing gums, which reduces the growth of Streptococcus pneumoniae in children with recurrent otitis media. There were fewer attacks as well as reduced antibiotic requirements in the above group of children.
Prevenion of AOM
Preventing acute otitis media is a high-priority area and vaccines, both against bacteriae and viruses, appear to hold considerable promise for the ultimate prevention of AOM. *~ In a recent development, Respiratory Syncytial Virus-enriched Immunoglobulin (RSVIg) has been sucessfully used in the prophylaxis of AOM in high-risk children. 4s,46 Although AOM develops in upto one-third of children with RSV illness, this approach appeared to have a significant impact on both RSV and non-RSV related AOM in high-risk children ( e. g. broncho-pulmonary dysplasia, prematurity and heart disease). In the future, we are likely to witness significant work in the development of vaccines for the prevention of acute otitis media.
Outcome and factors affect'rig outcome
Acute otitis media is essentially a self-limited disease and a poor outcome is fortunately rare. Perforation of the tympanic membrane occurs in about one-third of cases, of which more than 90% close within one month. 47 However, a middle-ear effusion persists for upto 3 months after the acute episode in about 70% of cases. In 10% it persists even beyond this period, usually requiring myringotomy with insertion of ventilating tubes.48Air-conduction and innerear function are unaffected 49, so in the absence of complications, though recently hearing threshold elevation in the high-frequency range ( > 8kHz) has been reported following AOM. 5) Animal studies have indicated that this might be due to inner ear dysfunction. Rarely facial palsy may be the presenting feature of AOM. s2 In most cases of facial palsy due to AOM, complete recovery is the rule, and antibiotics with myringotomy is all that is requied. The risk of facial palsy in AOM seems to be highest in adults, s3
It is generally believed that acute mastoiditis has become very rare due to early antibiotic use. s4 However the incidence of 'masked' or latent mastoiditis as a result of protracted subacute otitis has gone up significantly, as a result of disease modification by increasing early antibiotic administration in AOM. s4
Intra-cranial complications like meningitis have been shown to be predisposed by cochlear abnormalities like the Mondini deformity, or dehiscent facial nerve, especially in the horizontal part. ss
In a recent Finnish study s6 of prognostic factors associated with a poor outcome of AOM, age below 2 years, history of allergic or respiratory symptoms, 6 hours or more of pc-treatment otalgia and Branhamella (Moraxella) catarrhalis in MEF were implicated with clinical failure of therapy. HIV infection and i m m u n ocompromised states are also associated with a higher incidence of complications.
Conclusions
Although the majority of cases of Acute otitis m e d i a c o n t i n u e to be treated by early administration of antibiotics, there is increasing awareness that the benefits of antibiotic treatment are only modest.' Despite increasing penicillin resistance, amoxycillin continues to be the drug of choice, though newer macrolides (Roxithromycin, Azithromycin and Clarithromycin), Amoxycillin-Clavulanate and Cefixime appear to be promising as secondline agents. Tympanocentesis with culture of midle-ear fluid is likely to be a key investigation for rational therapy in future, especially in cases of therapeutic failure of amoxycillin, Preventing AOM is a high-priority area at present, with current research aimed at developing vaccines and conducting trials. 44 Although antibioics have definitely improved the outcome of AOM with regard to complications, there is some concern about the rising incidence of masked or latent mastoiditis as a result of increased early antibiotic therapy, s4 More'prospective studies would be neded to elucidate the best mode of management of this very common condition.
